Team Health (TMH) PT Raised to $72 at Piper Jaffray Following IPC Deal

Go back to Team Health (TMH) PT Raised to $72 at Piper Jaffray Following IPC Deal

Leerink Partners Remain Bullish on TeamHealth Holdings (TMH) Following 2Q15 Results

August 5, 2015 9:10 AM EDT

Leerink Partners reiterated an Outperform rating and $80.00 price target on Team Health (NYSE: TMH) following 2Q15 report. Net revenue at $878MM beat consensus at $833B. Adjusted EPS at $0.70 beat consensus by 1.4%.

Analyst Ana Gupte commented, "TMH (OP) reported 2Q15 earnings today before market open. Net revenue beat consensus by 5.5% driven acquisitions and new contracts exhibiting sequential and YoY improvement... More

TeamHealth Holdings (TMH) Tops Q2 EPS by 1c

August 4, 2015 8:18 AM EDT

TeamHealth Holdings (NYSE: TMH) reported Q2 EPS of $0.70, $0.01 better than the analyst estimate of $0.69. Revenue for the quarter came in at $787 million versus the consensus estimate of $832.41 million.

For earnings history and earnings-related data on TeamHealth Holdings (TMH) click here.

... More

TeamHealth Holdings (TMH) to Acquire IPC Healthcare (IPCM) in ~$1.6B Deal

August 4, 2015 8:16 AM EDT

TeamHealth Holdings (NYSE: TMH) announced a definitive agreement to acquire IPC Healthcare Inc. ("IPC Healthcare") (Nasdaq: IPCM), a leading national acute hospitalist and post-acute provider organization, in an all-cash transaction with an enterprise value of approximately $1.6 billion or $80.25 per share. The boards of directors of both companies have approved the transaction.

"We are excited to announce this strategic transaction with IPC Healthcare to create the leading physician services organization spanning multiple specialties," said TeamHealth President and Chief Executive Officer, Mike Snow. "Through this combination, TeamHealth... More